Crocetin and crocin decreased cholesterol and triglyceride content of both breast cancer tumors and cell lines
Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro) with the known anticancer activity, have shown hypolipidemic effect in diabetes and atherosclerosis. Here, we investigated the effect of Crt...
Saved in:
Published in | Avicenna journal of phytomedicine Vol. 10; no. 4; pp. 384 - 397 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Iran
Mashhad University of Medical Sciences
01.07.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro) with the known anticancer activity, have shown hypolipidemic effect in diabetes and atherosclerosis. Here, we investigated the effect of Crt/Cro on lipid content in breast cancer.
A multi-model approach involving
and
studies was applied. The 4T1-induced breast cancer in mice was used to investigate the effect of Crt/Cro on cholesterol (Chl) and triglyceride (TG) levels in serum and tumor tissues. The Chl/TG levels were also assessed in the cytosol of MDA-MB-231 and MCF-7 breast cancer cell lines 6, 12 and 24 hr after Crt/Cro treatment. The interaction between Crt/Cro and hydroxymethylglutaryl coenzyme A reductase (HMGCR) was also computed by docking analysis.
Crt reduced both serum (p=0.003) and tumor (p=0.011) Chl and TG (p=0.001) levels in mice. Cro reduced TG levels in tumor (p=0.014) and serum (p=0.002) and Chl level in tumor (p=0.013) tissues. Crt reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Cro reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Crt binds to the active site of HMGCR with higher affinity (ΔG
=-6.6 kcal/mol) than simvastatin (ΔG
=-6.0 kcal/mol).
Crt and Cro effectively decreased Chl/TG content in the sera of tumor bearing mice, in breast tumors and breast cancer cell lines. Crt showed a higher hypolipidemic potential than Cro.
analysis indicated Crt binding in the HMGCR active site. |
---|---|
AbstractList | OBJECTIVEInhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro) with the known anticancer activity, have shown hypolipidemic effect in diabetes and atherosclerosis. Here, we investigated the effect of Crt/Cro on lipid content in breast cancer. MATERIALS AND METHODSA multi-model approach involving in vivo, in vitro and in silico studies was applied. The 4T1-induced breast cancer in mice was used to investigate the effect of Crt/Cro on cholesterol (Chl) and triglyceride (TG) levels in serum and tumor tissues. The Chl/TG levels were also assessed in the cytosol of MDA-MB-231 and MCF-7 breast cancer cell lines 6, 12 and 24 hr after Crt/Cro treatment. The interaction between Crt/Cro and hydroxymethylglutaryl coenzyme A reductase (HMGCR) was also computed by docking analysis. RESULTSCrt reduced both serum (p=0.003) and tumor (p=0.011) Chl and TG (p=0.001) levels in mice. Cro reduced TG levels in tumor (p=0.014) and serum (p=0.002) and Chl level in tumor (p=0.013) tissues. Crt reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Cro reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Crt binds to the active site of HMGCR with higher affinity (ΔG0=-6.6 kcal/mol) than simvastatin (ΔG0 =-6.0 kcal/mol). CONCLUSIONCrt and Cro effectively decreased Chl/TG content in the sera of tumor bearing mice, in breast tumors and breast cancer cell lines. Crt showed a higher hypolipidemic potential than Cro. In silico analysis indicated Crt binding in the HMGCR active site. Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro) with the known anticancer activity, have shown hypolipidemic effect in diabetes and atherosclerosis. Here, we investigated the effect of Crt/Cro on lipid content in breast cancer. A multi-model approach involving and studies was applied. The 4T1-induced breast cancer in mice was used to investigate the effect of Crt/Cro on cholesterol (Chl) and triglyceride (TG) levels in serum and tumor tissues. The Chl/TG levels were also assessed in the cytosol of MDA-MB-231 and MCF-7 breast cancer cell lines 6, 12 and 24 hr after Crt/Cro treatment. The interaction between Crt/Cro and hydroxymethylglutaryl coenzyme A reductase (HMGCR) was also computed by docking analysis. Crt reduced both serum (p=0.003) and tumor (p=0.011) Chl and TG (p=0.001) levels in mice. Cro reduced TG levels in tumor (p=0.014) and serum (p=0.002) and Chl level in tumor (p=0.013) tissues. Crt reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Cro reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Crt binds to the active site of HMGCR with higher affinity (ΔG =-6.6 kcal/mol) than simvastatin (ΔG =-6.0 kcal/mol). Crt and Cro effectively decreased Chl/TG content in the sera of tumor bearing mice, in breast tumors and breast cancer cell lines. Crt showed a higher hypolipidemic potential than Cro. analysis indicated Crt binding in the HMGCR active site. Objective: Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro) with the known anticancer activity, have shown hypolipidemic effect in diabetes and atherosclerosis. Here, we investigated the effect of Crt/Cro on lipid content in breast cancer. Materials and Methods: A multi-model approach involving in vivo, in vitro and in silico studies was applied. The 4T1-induced breast cancer in mice was used to investigate the effect of Crt/Cro on cholesterol (Chl) and triglyceride (TG) levels in serum and tumor tissues. The Chl/TG levels were also assessed in the cytosol of MDA-MB-231 and MCF-7 breast cancer cell lines 6, 12 and 24 hr after Crt/Cro treatment. The interaction between Crt/Cro and hydroxymethylglutaryl coenzyme A reductase (HMGCR) was also computed by docking analysis. Results: Crt reduced both serum (p=0.003) and tumor (p=0.011) Chl and TG (p=0.001) levels in mice. Cro reduced TG levels in tumor (p=0.014) and serum (p=0.002) and Chl level in tumor (p=0.013) tissues. Crt reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Cro reduced both Chl and TG in MDA-MB-231 (p=0.014 and p=0.002, respectively) and MCF-7 (p=0.014 and p=0.002, respectively), after 24 h. Crt binds to the active site of HMGCR with higher affinity (ΔG0=-6.6 kcal/mol) than simvastatin (ΔG0 =-6.0 kcal/mol). Conclusion: Crt and Cro effectively decreased Chl/TG content in the sera of tumor bearing mice, in breast tumors and breast cancer cell lines. Crt showed a higher hypolipidemic potential than Cro. In silico analysis indicated Crt binding in the HMGCR active site. |
Author | Hashemi, Seyed Ali Bathaie, Seyedeh Zahra Mohagheghi, Mohammad Ali |
AuthorAffiliation | 1 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 2 Cancer Research Center of Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran |
AuthorAffiliation_xml | – name: 2 Cancer Research Center of Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran – name: 1 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran |
Author_xml | – sequence: 1 givenname: Seyed Ali surname: Hashemi fullname: Hashemi, Seyed Ali organization: Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran – sequence: 2 givenname: Seyedeh Zahra surname: Bathaie fullname: Bathaie, Seyedeh Zahra organization: Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran – sequence: 3 givenname: Mohammad Ali surname: Mohagheghi fullname: Mohagheghi, Mohammad Ali organization: Cancer Research Center of Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32850295$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUFvVCEUhUlT09batTvzlm5mhMvjARuTZmK1pokudE14cGeGhoEKjEn_fWmnNpYNl8vhO-Hct-Q45YSEvGd0CUC5-nT5_ecSKNNLNnIJR-QMANRC6lEfv9ScnpKLWm9pX5MahRAn5JSDEhS0OCNpVbLDFtJgkx9cP_TSoytoK_bGNkesDUuOT4JWwibeOyzB4-ByapjakNfDnNt2mB8ftcHZ1AVD2-9yqQcsxjjEkLC-I2_WNla8eN7Pye-rL79W3xY3P75ery5vFo5T1RaCWWWlR1i70TpGZ65ATcxPgJRqjVRyMdtJ2HlSfAQ5gWN69g74yBl45Ofk-sD12d6auxJ2ttybbIN5auSyMba04CKa9cS91dZPbhajAmmpH6VEZBpw7rl21ucD624_79C7_uVi4yvo65sUtmaT_xo5cqqF7oCPz4CS_-x7nGYX6mMmNmHeVwPdpU-GUt6lH_73ejH5NzD-ABROnDk |
CitedBy_id | crossref_primary_10_3389_fphar_2021_745683 |
ContentType | Journal Article |
DBID | NPM 7X8 5PM DOA |
DOI | 10.22038/AJP.2019.14372 |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2228-7949 |
EndPage | 397 |
ExternalDocumentID | oai_doaj_org_article_f63da9ad6cb54827a0d477ee192eb437 32850295 |
Genre | Journal Article |
GroupedDBID | 5VS ABDBF ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBD ESX GROUPED_DOAJ HYE IAO IHR IPNFZ ITC KQ8 M48 M~E NPM OK1 QF4 QN7 RIG RNS RPM TUS 7X8 5PM |
ID | FETCH-LOGICAL-c308t-51a8a7de2fc4ac10b382861d62e0099e0735ba65ab68342762c19bdc234312de3 |
IEDL.DBID | RPM |
ISSN | 2228-7930 |
IngestDate | Tue Oct 22 15:07:22 EDT 2024 Tue Apr 09 21:52:29 EDT 2024 Fri Aug 16 07:28:21 EDT 2024 Sat Sep 28 08:20:39 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Docking 4T1-induced breast tumor MDA-MB-231 Binding affinity HMGCR MCF-7 Lipid content |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c308t-51a8a7de2fc4ac10b382861d62e0099e0735ba65ab68342762c19bdc234312de3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430959/ |
PMID | 32850295 |
PQID | 2437845003 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f63da9ad6cb54827a0d477ee192eb437 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7430959 proquest_miscellaneous_2437845003 pubmed_primary_32850295 |
PublicationCentury | 2000 |
PublicationDate | 2020-07-01 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran – name: Mashhad, Iran |
PublicationTitle | Avicenna journal of phytomedicine |
PublicationTitleAlternate | Avicenna J Phytomed |
PublicationYear | 2020 |
Publisher | Mashhad University of Medical Sciences |
Publisher_xml | – name: Mashhad University of Medical Sciences |
SSID | ssj0000684555 |
Score | 2.2593439 |
Snippet | Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and crocin (Cro)... OBJECTIVEInhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and... Objective: Inhibition of lipid metabolism in breast cancer has been suggested as an effective approach for cancer therapy. Saffron-derived crocetin (Crt) and... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 384 |
SubjectTerms | 4t1-induced breast tumor docking hmgcr lipid content mcf-7 mda-mb-231 Original |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-RAEG7E015E3VXHF70gngymX3kcVVZkQfGg4C30o4LKmMgkc5h_b1V6VmdkwYu30HlV-qtUf9V0fc3YUYksxOFAlFjIfKJV8IlzPsdURXirPNRloGrk65vs6l7_fTAPC1t90ZqwKA8cO-60zlSwpQ2Zd4YkK20adJ4DIDMBp1WsIxdmIZmKMbjQZtjylGY4EnTCNOr6SJmq4tQ-k1SlKDFOKNIGHuT6_8cxPy-VXBh7LtfZ2pw08rNo7AZbgWaTHd9G1enZCb_7KKLqTvgxv_3Qo579ZM0FDVL9U8NtEzgGXo-HYaCLHWAD7ZBLcgnteLigx3x9PPPomQE4rWRHm3hbc4eYckc39dyTr0x4P31pJ118LIzHnChr94vdX_65u7hK5tssJF6lRZ8YYQubB5C119aL1CkqLRchk0D8ETAIGGczY11WKC0xenpRuuClQvIhA6gtttq0DewwjnQg15iea1WDxgMETtpc1MJK9ABfjNg59XT1GpU0KtK2HhoQ8WqOePUV4iP2-x9OFf4L9H22gXbaVSSuiLhjoBqx7Yjb-6uULEwqSzNi-RKiS7Ysn2meHge9bSRZNFu6-x3G77EfkjL2YcHvPlvtJ1M4QFrTu8PBg98AmNP5Eg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS-QwEA-iIL4c6n2tX-RAfLJ3bZJ-PYioKCIo--CCbyUf0zuhtndtF9z_3pm2ureyvoW0SdPMZPKbMPkNY4cpohCDG5GnIbKeks56xtgYXZXAamkhTx3dRr69i64n6uYhfJinAxomsFnq2lE-qUld_Hz-NzvFBX9CYczCl8mvs5sxBWmluOxljPZ4TSipSN1vB6zfm-VEhV0WVDr08FAv_Z7qZ1kfG2xdiiT0BeWd6Mj8lyHQ94GU_-1MV5vs0wAp-VmvA1tsBcptdjTuOalnx_x-fsWqOeZHfDxnq559ZuUFbWHtY8l16TiaZYtF14HJBrCC8ucSmUJVdC-06M0XM4t664BTnDuOiVc5NyhxbqhRyy1pUs3b6VNVN323UBScAG3zhU2uLu8vrr0hCYNnpZ-0XhjoRMcORG6VtoFvJF08D1wkgNAloIkIjY5CbaJEKoG21QapcVZIhCbCgfzKVsuqhO-MI1iIFTrvSuagsKBTLXQc5IEWqB82GbFzmunsb8-zkRHzdVdR1b-zYSFleSQdNnSRNSFRmGrfqTgGQKQKBkU3Yj9e5ZThSqH_0yVU0yYj6kVUATRjI_atl9vbp16FPWLxgkQXxrL4pHz807FxIwSjs9SdD_vcZRuCnPQuxnePrbb1FPYRybTmoNPQF5eD8h0 priority: 102 providerName: Scholars Portal |
Title | Crocetin and crocin decreased cholesterol and triglyceride content of both breast cancer tumors and cell lines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32850295 https://search.proquest.com/docview/2437845003 https://pubmed.ncbi.nlm.nih.gov/PMC7430959 https://doaj.org/article/f63da9ad6cb54827a0d477ee192eb437 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBbannYZ9l72KDRg6KlubEm27GMXrCgKZMihBXoz9KC3AI5cxM4h_36knKzNsNMuhiBbtmzS5EeB-sjY1wpRiEVHlBgoXKKkd4m1TmOokjkjHTSVp93I8x_F9Z26uc_vj1i-3wsTk_adXV6EdnURlr9ibuXDyk33eWLTxXyGXo-Wr6bH7FhL-SREH81vqfJY7ZQWNxLUv3Sk9BEileX08mZBCV0VmgipqZaNFGWeCqovEUn7_4U0_06YfOKBrl6w5zvoyC_HKb5kRxBesbPFyD29Pee3j1up-nN-xhePrNTb1yzMyFUNy8BN8BzNr8Omj6CxB-ygOrlEmtC18YIBo_Z261A_PXDKZ8c58a7hFiXLLQ0auCONWfNhs-rW_XhbaFtOwLV_w-6uvt_OrpNdsYXEybQckjwzpdEeROOUcVlqJW0wz3whgFAkoCnIrSlyY4tSKoE21GWV9U5IhCDCg3zLTkIX4D3jCAq0wiBdyQYUNkxlhNFZkxmBeuDKCftGX7p-GPk0amK4jh3d-me9k3PdFNLjQF84mxNVqUm90hoAESlYFN2EfdnLqcY_gt7PBOg2fU0Ui6gCaK4m7N0otz-P2gt7wvSBRA_mcngGlTCybu-U7sN_j_zIngkK1mOu7yd2Mqw38BkRzWBP40oAHueqPI3a_Bvw4vp- |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,24346,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swED6k6dAufTd1nyxQZIpsidRzTI0GbhoHHpwim8CXUqOyFFjy4P763lFWEwdd2o0gRYkUPx4_EsfvAD5lyEIULkSetLH2QmG0p5ROcKsSaCm0LTJDt5Gn5_HkIjy9jC73IOrvwjinfa0Ww6pcDqvFD-dbeb3Uo95PbDSbjnHVo-Or0T24j_OVR7c26Z0BTsPIxTul4w0PEeh3oj6c-yIdHZ_OyKUrQyMhEopmI3ga-ZwiTDjZ_r9xzbsuk7fWoJPH8L1vfed68nO4btVQ_7oj7PjP3XsCj7aslB13xU9hz1bP4HDWyVpvjtj85pZWc8QO2exG8HrzHKoxrYLtomKyMgwtu8akcXy0sZhBIXhJj6Eu3QPtanFVbjRC31hGrvLYWVYXTCFomKJKLdMExhVr18t61XSvtWXJiBM3L-Di5Mt8PPG2cRw8Lfy09aJApjIxlhc6lDrwlaC764GJuSWCatHKRErGkVRxKkKO5lkHmTKaC2Q33FjxEvarurKvgCHfSELc_4eisCEmZCa5TIIikBwhptMBfKYhzK87qY6cxLNdRr26yrf_OC9iYbCiibWKSAVV-iZMEmuR7FqFmBjAxx4AOU426p-sbL1uclJvRGyhJRzAQQeIP5_qUTSAZAcqO23ZLUEAOEHv7YC__u-aH-DBZD49y8--nn97Aw85nQk4l-K3sN-u1vYdEqdWvXfT5Dc83Rq5 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIhLecOWl5FQT80msZM4OZaFVSm0yqGVKi6RXykrsskqyR6WX8-Ms0t3K069WX4kcfx5_Nkaf0PIpwxYiIKFyJM20V7EjfaU0gK2KqGWXNsyM3gb-ew8ObmMTq_iq61QX85pX6vZuK7m43r2y_lWLuba3_iJ-fnZBFY9PL7yF6b075MHMGeZ2NqoD0Y4jWIX8xSPODxAYTAI-zAW8NQ_Ps3RrSsDQ8EFRrThLI0DhlEmnHT___jmbbfJrXVo-pj83PRgcD_5PV72aqz_3BJ3vFMXn5D9NTulx0OVp-SerZ-Rw3yQt14d0Yub21rdET2k-Y3w9eo5qSe4GvazmsraULDwGpLG8dLOQgaG4kVdhqZyFfp2dl2tNEwBYym6zEOHaVNSBeChChv1VCMoW9ov503bDY-1VUWRG3cvyOX068XkxFvHc_A0D9Lei0OZSmEsK3UkdRgojnfYQ5Mwi0TVgrWJlUxiqZKURwzMtA4zZTTjwHKYsfwl2aub2r4mFHiHiKyCgtJGkJCZZFKEZSgZQE2nI_IZh7FYDJIdBYpou4ymvS7W_7koE26goUm0ilENVQYmEsJaIL1WAS5G5OMGBAVMOuyfrG2z7ApUcQR8gUUckVcDKP69aoOkERE7cNn5lt0SAIET9l4P-sGdW34gD_Mv0-LHt_Pvb8gjhkcDzrP4Ldnr26V9B_ypV-_dTPkL_UQdOQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Crocetin+and+crocin+decreased+cholesterol+and+triglyceride+content+of+both+breast+cancer+tumors+and+cell+lines&rft.jtitle=Avicenna+journal+of+phytomedicine&rft.au=Hashemi%2C+Seyed+Ali&rft.au=Bathaie%2C+Seyedeh+Zahra&rft.au=Mohagheghi%2C+Mohammad+Ali&rft.date=2020-07-01&rft.issn=2228-7930&rft.volume=10&rft.issue=4&rft.spage=384&rft_id=info:doi/10.22038%2FAJP.2019.14372&rft_id=info%3Apmid%2F32850295&rft.externalDocID=32850295 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2228-7930&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2228-7930&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2228-7930&client=summon |